{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:05:57Z","timestamp":1791450357862,"version":"4.3.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01378"],"award-info":[{"award-number":["PI16\/01378"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01358"],"award-info":[{"award-number":["PI15\/01358"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijantimicag.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:03:15Z","timestamp":1562673795000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli"],"prefix":"10.1016","volume":"54","author":[{"given":"Rafael","family":"Ayerbe-Algaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Gil-Marqu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mir\u00f3-Canturri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Parra-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Pach\u00f3n-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Enrique","family":"Jim\u00e9nez-Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-8384","authenticated-orcid":false,"given":"Younes","family":"Smani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0001","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0002","article-title":"Polymyxins: to combine or not to combine?","volume":"8","author":"Perez","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0003","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011)","volume":"78","author":"Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0006","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vetpar.2014.09.022","article-title":"Efficacy of oxyclozanide against adult Paramphistomum leydeni in naturally infected sheep","volume":"206","author":"Sanabria","year":"2014","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0008","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","article-title":"Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"8","author":"Ayerbe-Algaba","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0009","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2016"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0010","series-title":"European antimicrobial breakpoints","year":"2016"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0011","first-page":"3405","article-title":"Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy","volume":"73","author":"Parra","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02574-18","article-title":"The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in Gram-negative bacilli","volume":"63","author":"Domalaon","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ja.2015.127","article-title":"Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii","volume":"69","author":"Tran","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0014","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41429-019-0186-8","article-title":"Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli","volume":"72","author":"Domalaon","year":"2019","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4102\/jsava.v70i2.756","article-title":"The pharmacology of halogenated salicylanilides and their anthelmintic use in animals","volume":"70","author":"Swan","year":"1999","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0016","first-page":"316","article-title":"Comparative pharmacokinetics of levamisole\u2013oxyclozanide combination in sheep and goats following per os administration","volume":"78","author":"Gokbulut","year":"2014","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2885.1987.tb00089.x","article-title":"The pharmacodynamics of the flukicidal salicylanilides, rafoxanide, closantel and oxyclozanide","volume":"10","author":"Mohammed-Ali","year":"1987","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0018","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.bmcl.2019.03.032","article-title":"Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and\/or colistin resistant Enterobacteriaceae isolates","volume":"29","author":"Xu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0019","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acs.molpharmaceut.5b00098","article-title":"Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: development of inhalable formulations through nanosuspension technology","volume":"12","author":"Costabile","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ijantimicag.2019.07.006_bib0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:43:32Z","timestamp":1778766212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0924857919301864"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.07.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}